Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab

NCT02338245 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: ASLAN001
DRUG: Lapatinib
DRUG: Capecitabine

Sponsor

ASLAN Pharmaceuticals